You are viewing an incomplete version of our website. Please click to reload the website as full version.

SQSTM1 antibody (Sequestosome 1) (AA 300-360)

Details for Product anti-SQSTM1 Antibody No. ABIN350828, Supplier: Log in to see
Antigen
  • SQSTM1
  • sqstm1
  • MGC79491
  • A170
  • OSIL
  • PDB3
  • ZIP3
  • p60
  • p62
  • p62B
  • OSF-6
  • Osi
  • STAP
  • ZIP
  • sb:cb621
  • zgc:85784
Alternatives
anti-Human SQSTM1 antibody for Immunohistochemistry (Frozen Sections)
Epitope
AA 300-360
45
19
19
18
17
14
13
13
7
6
5
5
5
5
5
5
3
2
2
2
2
1
1
1
1
1
1
1
1
Reactivity
Human
205
35
33
3
2
1
1
1
Host
Rabbit
154
44
4
3
Clonality
Polyclonal
Conjugate
This SQSTM1 antibody is un-conjugated
11
10
10
8
8
8
3
3
3
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
139
75
60
41
36
35
31
27
11
9
5
3
2
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen A synthetic peptide from aa region 300-360 of human SQSTM1 has been used as the antigen.
Isotype IgG
Specificity Specific for sequestosome-1.
Alternative Name SQSTM1 (SQSTM1 Antibody Abstract)
Background Function: Adapter protein which binds ubiquitin and may regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1. May play a role in titin/TTN downstream signaling in muscle cells. May regulate signaling cascades through ubiquitination. May be involved in cell differentiation, apoptosis, immune response and regulation of K(+) channels.
Subcellular location: Cytoplasm. Late endosome. Nucleus. Note=Sarcomere. In cardiac muscles localizes to the sarcomeric band. Localizes to late endosomes. May also localize to the nucleus. Accumulates in neurofibrillary tangles and in Lewy bodies of neurons from individuals with Alzheimer and Parkinson disease respectively. Enriched in Rosenthal fibers of pilocytic astrocytoma. In liver cells, accumulates in Mallory bodies associated with alcoholic hepatitis, Wilson disease, indian childhood cirrhosis and in hyaline bodies associated with hepatocellular carcinoma.
Tissue specificity: Ubiquitously expressed. Also known as: Sequestosome 1, phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa, ubiquitin-binding protein p62, EBI3-associated protein of 60 kDa, p60, EBIAP, SQSTM1, A170, OSIL, PDB3, ZIP3, p62B.
Pathways NF-kappaB Signaling, Neurotrophin Signaling Pathway
Application Notes Use at a concentration of 10-50 µg/ml.
The optimal concentration should be determined by the end user.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Background publications Olsen, Blagoev, Gnad et al.: "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." in: Cell, Vol. 127, Issue 3, pp. 635-48, 2006 (PubMed).

Nousiainen, Silljé, Sauer et al.: "Phosphoproteome analysis of the human mitotic spindle." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 14, pp. 5391-6, 2006 (PubMed).

Good, Busfield, Fletcher et al.: "Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees." in: Bone, Vol. 35, Issue 1, pp. 277-82, 2004 (PubMed).

Hocking, Lucas, Daroszewska et al.: "Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences." in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 19, Issue 7, pp. 1122-7, 2004 (PubMed).

Ciani, Layfield, Cavey et al.: "Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone." in: The Journal of biological chemistry, Vol. 278, Issue 39, pp. 37409-12, 2003 (PubMed).

Hocking, Lucas, Daroszewska et al.: "Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease." in: Human molecular genetics, Vol. 11, Issue 22, pp. 2735-9, 2002 (PubMed).

Stumptner, Heid, Fuchsbichler et al.: "Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent." in: The American journal of pathology, Vol. 154, Issue 6, pp. 1701-10, 1999 (PubMed).

Vadlamudi, Joung, Strominger et al.: "p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins." in: The Journal of biological chemistry, Vol. 271, Issue 34, pp. 20235-7, 1996 (PubMed).

Joung, Strominger, Shin: "Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 12, pp. 5991-5, 1996 (PubMed).

Devergne, Hummel, Koeppen et al.: "A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes." in: Journal of virology, Vol. 70, Issue 2, pp. 1143-53, 1996 (PubMed).